1 – 10 of 60
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
A Narrative Review on Central Neuraxial Blocks and Direct Oral Anticoagulants
(
- Contribution to journal › Article
- 2023
-
Mark
Infrastructural considerations of implementing gene therapy for hemophilia in the Nordic context
(
- Contribution to journal › Article
-
Mark
Methods for anti-factor VIII antibody levels in haemophilia A patients-validation of a multiplec immunoassay and comparability with assays measuring non-neutralising and neutralising antibodies (inhibitors)
(
- Contribution to journal › Article
- 2022
-
Mark
Antiphospholipid antibodies in patients with myocardial infarction with and without obstructive coronary arteries
(
- Contribution to journal › Article
-
Mark
Factor IX antibodies and tolerance in hemophilia B in the Nordic countries - The impact of F9 variants and complications
(
- Contribution to journal › Article
- 2021
-
Mark
Validation of factor VIII activity for monitoring standard and extended half-life products and correlation to thrombin generation assays
(
- Contribution to journal › Article
- 2020
-
Mark
Unveiling the complex effects of direct oral anticoagulants on dilute Russell's viper venom time assays
(
- Contribution to journal › Article
- 2019
-
Mark
Evaluation of a standardized protocol for thrombin generation using the calibrated automated thrombogram : A Nordic study
(
- Contribution to journal › Article
-
Mark
The Coagulopathy of Acute Type A Aortic Dissection : A Prospective, Observational Study
(
- Contribution to journal › Article
-
Mark
Low-molecular-weight heparin adherence and effects on survival within a randomised phase III lung cancer trial (RASTEN)
(
- Contribution to journal › Article